These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 978210)

  • 61. Decreased chloride levels of cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
    Watanabe S; Kimura T; Suenaga K; Wada S; Tsuda K; Kasama S; Takaoka T; Kajiyama K; Takeda M; Yoshikawa H
    J Neurol Sci; 2009 Oct; 285(1-2):146-8. PubMed ID: 19595376
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cerebrospinal fluid levels of chromogranin A and phosphorylated neurofilament heavy chain are elevated in amyotrophic lateral sclerosis.
    Kaiserova M; Grambalova Z; Otruba P; Stejskal D; Prikrylova Vranova H; Mares J; Mensikova K; Kanovsky P
    Acta Neurol Scand; 2017 Oct; 136(4):360-364. PubMed ID: 28185258
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differential expression of microRNA-206 in the gastrocnemius and biceps brachii in response to CSF from sporadic amyotrophic lateral sclerosis patients.
    Sumitha R; Sidhu RJ; Sathyaprabha TN; Nalini A; Raju TR; Alladi PA
    J Neurol Sci; 2014 Oct; 345(1-2):254-6. PubMed ID: 25039065
    [No Abstract]   [Full Text] [Related]  

  • 64. Vascular endothelial growth factor attenuates neurodegenerative changes in the NSC-34 motor neuron cell line induced by cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients.
    Kulshreshtha D; Vijayalakshmi K; Alladi PA; Sathyaprabha TN; Nalini A; Raju TR
    Neurodegener Dis; 2011; 8(5):322-30. PubMed ID: 21389676
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z; Dobosz B
    Acta Neurol Scand; 2001 Apr; 103(4):255-8. PubMed ID: 11328198
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cerebrospinal Fluid from Sporadic Amyotrophic Lateral Sclerosis Patients Induces Mitochondrial and Lysosomal Dysfunction.
    Sharma A; Varghese AM; Vijaylakshmi K; Sumitha R; Prasanna VK; Shruthi S; Chandrasekhar Sagar BK; Datta KK; Gowda H; Nalini A; Alladi PA; Christopher R; Sathyaprabha TN; Raju TR; Srinivas Bharath MM
    Neurochem Res; 2016 May; 41(5):965-84. PubMed ID: 26646005
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Neurospecific proteins in cerebrospinal fluid and in the bloodserum of patients with amyotrophic lateral sclerosis].
    Rushkevich YN; Pashkouskaya ID; Likhachev SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(5):75-80. PubMed ID: 29927408
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression.
    Tortelli R; Ruggieri M; Cortese R; D'Errico E; Capozzo R; Leo A; Mastrapasqua M; Zoccolella S; Leante R; Livrea P; Logroscino G; Simone IL
    Eur J Neurol; 2012 Dec; 19(12):1561-7. PubMed ID: 22680408
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis.
    Barschke P; Oeckl P; Steinacker P; Ludolph A; Otto M
    Expert Rev Proteomics; 2017 Sep; 14(9):769-777. PubMed ID: 28799854
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment.
    Wormser U; Mandrioli J; Vinceti M; Fini N; Sintov A; Brodsky B; Proskura E; Finkelstein Y
    J Neuroinflammation; 2016 Jun; 13(1):131. PubMed ID: 27245439
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?
    Abdelhak A; Junker A; Brettschneider J; Kassubek J; Ludolph AC; Otto M; Tumani H
    Int J Mol Sci; 2015 Jul; 16(8):17565-88. PubMed ID: 26263977
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased mitochondrial oxidative damage and oxidative DNA damage contributes to the neurodegenerative process in sporadic amyotrophic lateral sclerosis.
    Murata T; Ohtsuka C; Terayama Y
    Free Radic Res; 2008 Mar; 42(3):221-5. PubMed ID: 18344116
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Biotransformation of nitric oxide in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Kokić AN; Stević Z; Stojanović S; Blagojević DP; Jones DR; Pavlović S; Niketić V; Apostolski S; Spasić MB
    Redox Rep; 2005; 10(5):265-70. PubMed ID: 16354415
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Determination of superoxide dismutase activity by the polarographic method of catalytic currents in the cerebrospinal fluid of aging brain and neurologic degenerative diseases.
    Bracco F; Scarpa M; Rigo A; Battistin L
    Proc Soc Exp Biol Med; 1991 Jan; 196(1):36-41. PubMed ID: 1984240
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Jiménez-Jiménez FJ; Hernánz A; Medina-Acebrón S; de Bustos F; Zurdo JM; Alonso H; Puertas I; Barcenilla B; Sayed Y; Cabrera-Valdivia F
    Acta Neurol Scand; 2005 Feb; 111(2):114-7. PubMed ID: 15644071
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis.
    Smith RG; Henry YK; Mattson MP; Appel SH
    Ann Neurol; 1998 Oct; 44(4):696-9. PubMed ID: 9778272
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis.
    Siciliano G; Piazza S; Carlesi C; Del Corona A; Franzini M; Pompella A; Malvaldi G; Mancuso M; Paolicchi A; Murri L
    J Neurol; 2007 May; 254(5):575-80. PubMed ID: 17426914
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro neurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses.
    Fiszman ML; Ricart KC; Latini A; Rodríguez G; Sica RE
    Acta Neurol Scand; 2010 Feb; 121(2):120-6. PubMed ID: 19804473
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
    Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid.
    Perry TL; Krieger C; Hansen S; Eisen A
    Ann Neurol; 1990 Jul; 28(1):12-7. PubMed ID: 2375629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.